Repligen Corp. buy Wolfe Research
Start price
29.04.25
/
50%
€123.75
Target price
29.04.26
€140.48
Performance (%)
-23.30%
End price
30.04.26
€94.92
Summary
This prediction ended on 30.04.26 with a price of €94.92. The price of Repligen Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.30%. Wolfe_Research has a follow-up prediction for Repligen Corp. where he still thinks Repligen Corp. is a Buy. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Repligen Corp. | -6.310% | -6.310% | 16.683% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Wolfe_Research for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat
In the thread Trading Repligen Corp.
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten